Filed May 23, 2025

Serial No. 99199767

Examining Attorney SHERIF G FARRAG

Class Pharmaceutical preparations, namely, single-administration gene therapy products for the treatment and long-term management of chronic diseases, namely, metabolic, autoimmune, cardiovascular, infectious disease, oncology, or neurological disorders; gene therapy products for medical purposes, namely, pharmaceutical preparations for the treatment of metabolic, autoimmune, cardiovascular, infectious disease, oncology, or neurological disorders; therapeutic preparations comprising viral vectors for gene delivery; biopharmaceuticals for modifying genetic expression to treat chronic and inherited conditions, namely, metabolic, autoimmune, cardiovascular, infectious disease, oncology, or neurological disorders; injectable gene therapy products for use in treating metabolic, autoimmune, cardiovascular, or neurological disorders; biologics in the nature of pharmaceutical preparations for the treatment of chronic diseases, metabolic, autoimmune, cardiovascular, infectious disease, oncology, or neurological disorders; biological preparations for the prevention or treatment of chronic diseases, namely, metabolic, autoimmune, cardiovascular, infectious disease, oncology, or neurological disorders; injectable pharmaceutical preparations for treatment of chronic diseases, namely, metabolic, autoimmune, cardiovascular, infectious disease, oncology, or neurological disorders; long-duration medicines for treatment of chronic diseases, namely, metabolic, autoimmune, cardiovascular, infectious disease, oncology, or neurological disorders; 005; 006; 018; 044; 046; 051; 052

Case Type Trademark